ESMO 25: Padcev/Keytruda Reduces Risk Of Death By Half In Bladder Cancer Trial

 
• By Kevin Grogan
  
Berlin is hosting this year's ESMO (Kevin Grogan)

More from Anticancer

More from Therapy Areas